...

TriCore Reference Laboratories Increases Its COVID-19 Testing Capacity


04/24/2020

******FOR IMMEDIATE RELEASE********
TRICORE REFERENCE LABORATORIES
INCREASES ITS COVID-19 TESTING CAPACITY

ALBUQUERQUE, NEW MEXICO – April 24, 2020 — TriCore Reference Laboratories has increased COVID-19 test capacity once again, adding the ability to test an additional 1000 samples each day, representing a greater than 50% increase.
“Based on reagent allocation and our diverse set of testing instruments, we are currently able to result 2700 COVID-19 samples each day while maintaining a 24-48 hour turnaround time,” said Dr. Karissa Culbreath, Medical Director and Infectious Disease Division Chief at TriCore. “Our strategy has always been to use multiple platforms to meet New Mexico’s capacity needs and to be able to maintain testing during potential reagent shortages by any one manufacturer. Testing supplies have been coming in more reliably, and we are confident in our ability to consistently deliver 2700 tests per day. In fact, without any of the reagent limitations, our instrument capacity is almost double that number.”
“I am pleased with the robust COVID-19 testing capacity at our Core Lab in Albuquerque, giving TriCore the ability to efficiently test samples from all over New Mexico in this centralized testing environment. Our next step will be to de-centralize appropriately into our hospital locations, allowing our hospital partners the agility to escalate high-priority patients as needed. We will take a collaborative, phased approach for de-centralization and will keep the public updated as we progress. All of this is significant in support of the Governor’s emphasis on testing for the state.” said Dr. Douglas Clark, Chief Medical Officer at TriCore.
Since launching the test on March 12, TriCore has resulted more than 28,000 COVID-19 tests. Additionally, as a part of screening for COVID-19, TriCore has performed almost 15,000 tests for other respiratory pathogens, including influenza and RSV. TriCore is proud to work alongside our government and healthcare partners in a collaborative COVID-19 response effort, aiming to optimize capacity, provide clarity and maximize coverage for the State of New Mexico. More information on TriCore’s approach can be found on tricore.org in the new COVID-19 Data Center: www.tricore.org/covid_19_data_center
_________________________________________ About TriCore Reference Laboratories About TriCore Reference Laboratories TriCore Reference Laboratories is an independent, not-for-profit, clinical reference laboratory founded and headquartered in Albuquerque, New Mexico, co-sponsored by Presbyterian Healthcare Services and University of New Mexico Health Sciences Center. TriCore provides over 2,900, full-service, state-of-the-art laboratory tests to healthcare professionals and their patients. TriCore also provides analytics and research services, supporting healthcare and scientific organizations worldwide. TriCore’s Rhodes Group offers laboratory software and consulting services to optimize clinical laboratory operations, including empowering population health management and targeted intervention strategies. For more information, visit tricore.org.

TriCore in the News

Recovered Patient Donates Plasma

Several hospitals in the state have in recent weeks started using convalescent plasma to try to treat COVID patients.

Albuquerque Journal,05/19/2020

What’s Next on the Point-of-Care Testing Menu?

From SARS-CoV-2 to cardiac biomarkers, a steady stream of IVD innovation shows no signs of letting up

Clinical Laboratory News,05/01/2020

Questions remain as NM begins antibody testing

Testing to see who has antibodies to the coronavirus has begun in New Mexico, but questions remain about how to use the results and what they actually mean.

Albuquerque Journal,04/30/2020

Opening the Magic Box: Lab professionals reveal their value during COVID-19

As the COVID-19 pandemic rolls with equal ferocity across big cities and rural communities, clinical laboratory professionals have stepped front and center onto the healthcare stage. In my view, we will stay in our newfound spotlight not only as the country grapples with this unprecedented public health crisis but also as it prepares as never before for future outbreaks.

LabPulse.com,04/20/2020

Recent Tweets

Follow us on Twitter